| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
RESEARCH REPORT |
1 First Department of Oral and Maxillo-Facial Surgery, Tokyo Dental College, 1-2-2 Masago, Mihama-ku, Chiba 261-8502, Japan;
2 Department of Clinical Molecular Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan;
3 Division of Oral Surgery, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan;
* corresponding author, uzawak{at}faculty.chiba-u.jp
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMATERIALS & METHODSRESULTSDISCUSSIONREFERENCES |
|---|
KEY WORDS: survivin • oral squamous cell carcinoma • DNA methylation • inhibitor of apoptosis
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS & METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Regarding oral squamous cell carcinomas (OSCC), it is unknown whether survivin is associated with oral carcinogenesis. In this study, we therefore examined the state of survivin mRNA and survivin protein expression in OSCCs and oral pre-malignant lesions. In addition, to determine whether expression of survivin could be regulated by an epigenetic mechanism, we evaluated the methylation status of the CpG sites in exon 1 of the survivin gene in DNA samples from primary tumors and adjacent normal tissues.
|
MATERIALS & METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS & METHODSRESULTSDISCUSSIONREFERENCES |
|---|
DNA/RNA Isolation
Genomic DNA was extracted by proteinase K digestion and the phenol-chloroform extraction procedure. Total RNA was isolated by means of an SV Total RNA Isolation System (Promega, Madison, WI, USA) according to the manufacturer’s protocol. The samples were stored at -80°C until use.
Immunohistochemistry
Immunohistochemical staining was performed on 4-µm sections of paraffin-embedded specimens with the use of goat anti-human Survivin polyclonal antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). In brief, after deparaffinization and hydration, the slides were treated with endogenous peroxidase in 0.3% H2O2 for 30 min, after which the sections were blocked for 2 hrs at room temperature with 1.5% blocking serum (Santa Cruz) in phosphate-buffered saline (PBS) before reacting with anti-Survivin antibody (1:100 dilution) at room temperature in a moist chamber for 30 min. After being washed with PBS buffer, the slides were treated with biotinylated secondary antibody and avidin-biotin enzyme reagent (Santa Cruz), followed by color development in 3,3'-diaminobenzidine tetrahydrochloride (DAKO JAPAN Inc., Kyoto, Japan). Finally, the slides were lightly counterstained with hematoxylin. As a negative control, duplicate sections were immunostained without exposure to primary antibodies. For quantitation of the state of survivin protein expression, the mean percentage of positive tumor cells was determined in at least five random fields at 400x magnification in each section. The intensity of the survivin immunoreaction then was scored as follows: 1+, weak; 2+, moderate; and 3+, intense. The percentage of positive tumor cells and the staining intensity were then multiplied to produce a survivin-immunohistochemical staining (survivin-IHC) score. Cases with a survivin-IHC score less than 100 were considered negative. These judgments were made by two independent pathologists, neither of whom had any knowledge or information pertaining to the patients’ clinical status. Any discrepancy in the scoring of slides was resolved jointly by the pathologists by discussion, and a consensus observation was recorded after discussion.
Statistical significance was evaluated by 
2 analysis, Fisher’s exact test, or Student’s t test.
RT-PCR
To create first-strand cDNA for the survivin gene, we used 500 ng of total RNA for the RT reaction. The reaction was performed with the use of a Ready-To-Go T-primer First-Strand Kit (Amersham Pharmacia Biotech, Uppsala, Sweden). Ten percent of the cDNA was amplified by PCR with a forward primer, 5'-AGAACTGGCCCTTCTTGGA-3', and a reverse primer, 5'-AAGGAAAGCGCAACCGGACG-3' in a final volume of 25 µL containing 12.5 µL of PCR Master Mix (Roche Molecular Biochemicals, Mannheim, Germany), 1 µL of the cDNA obtained from the RT reaction, 0.5 µL of each of the specific primers (20 pM), and 10.5 µL of water. To confirm the identity of the PCR products, we cloned them into a pCR 2.1 vector (Invitrogen, Carlsbad, CA, USA) and sequenced them on an ALF express IITM DNA Sequencer (Amersham Pharmacia Biotech). After PCR amplification, an aliquot of the PCR product was separated on a 3% agarose gel and stained with ethidium bromide. The density of the ethidium-bromide-stained bands was analyzed by NIH image 1.62. The results were normalized as a ratio of each specific mRNA signal to the glyceraldehye-3-phosphate dehydrogenase gene signal within the same RNA sample. cDNA obtained from normal oral epithelium was used as a negative control. We confirmed reproducibility by processing all samples at least twice.
Methylation Assay
To determine if methylation of a CpG island of the survivin exon 1 could contribute to the mRNA expression of survivin, we used a PCR-based methylation assay to analyzed DNA samples obtained from 9 pairs of OSCCs and corresponding normal oral tissues, and 8 OSCC-derived cell lines. In brief, 10 µg of DNA was digested with Hind III (1 µg/unit, Boehringer GmbH, Mannheim, Germany) at 37°C for 16 hrs. The digested DNAs were then precipitated with ethanol, dissolved in distilled water, and further digested with mCpG-sensitive Hpa II (1 µg/unit, Toyobo, Tokyo, Japan) at 37°C for 16 hrs. The Hpa II-digested DNAs then were amplified with specific primers for survivin exon 1 as previously reported by Hattori et al.(2001). The PCR reactions were performed in a final volume of 25 µL containing 1 µL of digested DNA, 2.5 pmol of each specific primer, 50 µM of dNTPs, 10 mM Tris-HCl buffer (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, and 0.5 unit of AmpliTaq Gold (Applied Biosystems, Foster City, CA, USA). The amplified PCR products were separated on 3% agarose gel and visualized by ethidium bromide after the run.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS & METHODSRESULTSDISCUSSIONREFERENCES |
|---|
. All normal oral mucosa specimens showed absence or significant down-regulation of survivin expression and were considered survivin-negative. Among the tumors examined, 41 cases (58%) revealed a survivin-immunoreaction in the cytoplasm of the tumor cells (Table). However, there was no statistically significant difference between survivin expression and clinicopathologic features (Table). More interestingly, 14 of 38 leukoplakias (37%) were considered survivin-positive. Representative results for survivin protein expression in normal oral tissue, leukoplakia, and primary OSCC are shown in Fig. 1.
|
|
). In contrast, we found no significant difference in survivin-IHC scores between OSCCs and leukoplakias (p = 0.3364, Fig. 2).
|
). No statistical significance was observed between the presence of the gene expression and any clinicopathologic features studied (data not shown).
|
. |
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS & METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Considerable evidence suggests that elevated expression of survivin may promote tumorigenesis, and in fact survivin is highly expressed in human common cancers (Kawasaki et al., 1998; Lu et al., 1998; Monzo et al., 1999; Tanaka et al., 2000; Gianani et al., 2001). In contrast, several recent studies have reported survivin gene expression in several normal tissues (Grossman et al., 1999; Gianani et al., 2001; Lehner et al., 2002). In our study, we found that the vast majority of normal tissues had no survivin mRNA expression, with the exception of one tissue specimen. At present, it is unclear why normal cells with survivin expression exist. One possible explanation is that the mRNA sample containing survivin mRNA may be obtained from mitotically active cells, because survivin has been shown to regulate the cell cycle in the G2-M phase (Li et al., 1998).
Lo Muzio et al.(2001) reported a significant correlation between survivin protein expression and tumor aggressiveness in OSCCs and skin SCC. The incidence of survivin expression was consistent with the present study that showed protein expression in 50% to 60% of the tumors analyzed. In laryngeal SCCs, survivin gene expression was closely associated with survival rates (Dong et al., 2002). Thus, we postulated that the state of survivin expression may be an important discriminator for the progression of head and neck SCCs. However, the results were not as good as expected, because we could not find a relation between the degree of survivin expression and the grade/stage of OSCC examined in this study. Thus, we hypothesize that survivin protein accumulation might be an early event during oral carcinogenesis, since one-third of oral pre-malignant lesions examined in this study had protein expression. In this context, the expression of survivin has been demonstrated in several types of pre-malignant lesions or early stages of cancer, including colon polyps (Gianani et al., 2001), pancreatic adenoma (Satoh et al., 2001), and Bowen diseases (SCC in situ) (Grossman et al., 1999). Further studies on a large series of patients will provide more accurate information about the involvement of survivin expression in the development of oral carcinogenesis.
It has been accepted that gene expression in cells is regulated by DNA methylation, and hypermethylation in the promoter region of a given tumor suppressor gene may lead to its inactivation. Regarding the survivin gene, the promoter region was reported to be unmethylated in both normal and tumor tissues (Li and Altieri, 1999). On the other hand, 86% of ovarian cancers were positive for survivin, whereas 83% of survivin-negative cases were methylation-positive for the gene (Hattori et al., 2001). More recently, a transfection experiment (Bao et al. 2002) showed that survivin expression in an ovarian cancer cell line could be controlled by transcriptional regulation. We also found similar evidence of survivin-methylation in normal tissues and tumors with no survivin expression. These observations raise the possibility that up-regulation of the survivin gene may be the result of epigenetic regulation. In addition to epigenetic regulation, survivin expression could be controlled by survivin-related protein, because one OSCC patient revealed no survivin-methylation with the absence of gene expression (Fig. 3). Recent in vitro studies have shown that survivin expression is regulated in transcriptional response by wt-p53 (Hoffman et al., 2002) or by wt-adenomatous polyposis coli protein (Zhang et al., 2001). Lu et al.(1998) reported a significant correlation between survivin expression and accumulation of mutant p53 in gastric cancer. It would therefore be interesting to determine if survivin expression could be correlated with these tumor suppressors in OSCCs.
Finally, recent studies have shown that targeting of survivin using survivin antisense cDNA or a survivin mutant adenovirus may be a useful approach for selective cancer gene therapy (Ambrosini et al., 1998; Mesri et al., 2001). These targeting strategies might also be novel therapeutic tools for human OSCCs.
|
ACKNOWLEDGMENTS |
|---|
Received September 12, 2002; Last revision January 21, 2003; Accepted March 25, 2003
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS & METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Ambrosini G, Adida C, Sirugo G, Altieri DC (1998). Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273:11177–11182.
Bao R, Connolly DC, Murphy M, Green J, Weistein JK, Pisarcik DA, et al. (2002). Activation of cancer-specific gene expression by the survivin promoter. J Natl Cancer Inst 94:522–528.
Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, et al. (1998). IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17:2215–2223.[ISI][Medline]
Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M (2002). Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res 22:2377–2383.[ISI][Medline]
Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R, et al. (2001). Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 32:119–125.[ISI][Medline]
Grossman D, McNiff JM, Li F, Altieri DC (1999). Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest 79:1121–1126.[ISI][Medline]
Hattori M, Sakamoto H, Satoh K, Yamamoto T (2001). DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett 169:155–164.[ISI][Medline]
Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M (2002). Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277:3247–3257.
Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998). Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancers. Cancer Res 85:5071–5074.
Lehner R, Enomoto T, McGregor JA, Shroyer L, Haugen BR, Pugazhenthi U, et al. (2002). Correlation of survivin mRNA detection with histologic diagnosis in normal endometrium and endometrial carcinoma. Acta Obstet Gynecol Scand 81:162–167.[ISI][Medline]
Li F, Altieri DC (1999). Transcriptional analysis of human survivin gene expression. Biochem J 344:305–311.
Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. (1998). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580–584.[Medline]
Lo Muzio L, Staibano S, Pannone G, Mignogna MD, Mariggio A, Salvatore G, et al. (2001). Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 70:249–254.[ISI][Medline]
Lu CD, Altieri DC, Tanigawa N (1998). Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58:1808–1812.
Mesri M, Wall NR, Li J, Kim RW, Altieri DC (2001). Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest 108:981–990.[ISI][Medline]
Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, et al. (1999). A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognostic marker in non-small-cell lung cancers. J Clin Oncol 17:2100–2104.
Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A, Shimosegawa T (2001). Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 92:271–278.[ISI][Medline]
Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC (1999). Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341:452–453.
Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N (2000). Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6:127–134.
Thompson CB (1995). Apoptosis in pathogenesis and treatment of disease. Science 267:1456–1462.
Vaux DL, Haecker G, Strasser A (1994). An evolutionary perspective on apoptosis. Cell 76:777–779.[ISI][Medline]
Zhang T, Otevrel T, Gao Z, Gao Z, Ehrlich SM, Fields JZ, et al. (2001). Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61:8664–8667.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |
X174-HaeIII). (A) RT-PCR analysis with the use of specific primers for survivin gene showed that survivin was expressed in tumors but not in corresponding normal tissues, except for case No. 8. Methylation assay revealed survivin-methylation in normal tissues of cases 17, 21, 9, and 13, respectively, which showed no survivin gene mRNA expression. (B) Survivin mRNA expression was detected in OSCC-derived cell lines (HSC-3, OK-92, Ca9-22, and SAS). All cell lines, with the exception of Ca9-22 cell line, showed survivin-methylation.